GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Royalty Pharma PLC (STU:RPD) » Definitions » Other Current Payables

Royalty Pharma (STU:RPD) Other Current Payables : €71 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Royalty Pharma Other Current Payables?

Royalty Pharma's Other Current Payables for the quarter that ended in Sep. 2024 was €71 Mil.

Royalty Pharma's quarterly Other Current Payables increased from Mar. 2024 (€84 Mil) to Jun. 2024 (€92 Mil) but then declined from Jun. 2024 (€92 Mil) to Sep. 2024 (€71 Mil).

Royalty Pharma's annual Other Current Payables declined from Dec. 2021 (€96 Mil) to Dec. 2022 (€89 Mil) and declined from Dec. 2022 (€89 Mil) to Dec. 2023 (€76 Mil).

Royalty Pharma Other Current Payables Historical Data

The historical data trend for Royalty Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Royalty Pharma Other Current Payables Chart

Royalty Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial 27.94 103.87 95.52 89.49 76.25

Royalty Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.30 76.25 84.10 91.54 71.31

Royalty Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Royalty Pharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of Royalty Pharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Royalty Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Royalty Pharma PLC (STU:RPD) » Definitions » Other Current Payables
Comparable Companies
LEGN INCY UTHR SRPT TECH BMRN JAZZ ROIV EXEL IONS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RPRX:USA RPRX:Mexico RPD:Germany
Address
110 East 59th Street, New York, NY, USA, 10022
Website
https://www.royaltypharma.com
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.